Harbour Investments’s Filana Therapeutics FLNA Stock Holding History

Harbour Investments’s Portfolio FLNA Stock Details FLNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$423	Hold	250	–	–	﹤0.01%	4285
2025 Q4	$495	Hold	250	–	–	﹤0.01%	3553
2025 Q3	$728	Hold	250	–	–	﹤0.01%	3461
2025 Q2	$453	Sell	250 -10	-4%	-$18	﹤0.01%	3391
2025 Q1	$390	Hold	260	–	–	﹤0.01%	3366
2024 Q4	$614	Sell	260 -800	-75%	-$14K	﹤0.01%	3248
2024 Q3	$31.2K	Hold	1,060	–	–	﹤0.01%	1875
2024 Q2	$13.1K	Hold	1,060	–	–	﹤0.01%	2150
2024 Q1	$21.5K	Hold	1,060	–	–	﹤0.01%	1921
2023 Q4	$23.9K	Hold	1,060	–	–	﹤0.01%	1790
2023 Q3	$17.6K	Buy	1,060 +800	+308%	+$15.9K	﹤0.01%	1801
2023 Q2	$6.38K	Hold	260	–	–	﹤0.01%	2202
2023 Q1	$6.27K	Hold	260	–	–	﹤0.01%	2203
2022 Q4	$7.68K	Hold	260	–	–	﹤0.01%	2065
2022 Q3	$7K	Hold	260	–	–	﹤0.01%	2076
2022 Q2	$7K	Buy	+260	New	+$6.57K	﹤0.01%	2076
2021 Q4	$11K	Sell	250 -500	-67%	-$26.2K	﹤0.01%	1903
2021 Q3	$47K	Sell	750 -310	-29%	-$25.9K	﹤0.01%	1807
2021 Q2	$91K	Buy	1,060 +790	+293%	+$42.3K	﹤0.01%	1452
2021 Q1	$12K	Buy	+270	New	+$10.6K	﹤0.01%	2511

Other funds holding FLNA

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Harbour Investments's FLNA Position: Q1 2026 in Review

Harbour Investments held its Filana Therapeutics (FLNA) position steady in Q1 2026 at 250 shares worth $423. The position accounts for ﹤0.01% of the portfolio, ranked #4285.

Harbour Investments first reported a position in FLNA in Q1 2021 and has held it in 20 quarters since. The position peaked at $91K in Q2 2021. 101 funds tracked by Wall St. Rank hold FLNA as of Q1 2026.

Harbour Investments held 250 shares of Filana Therapeutics worth $423 as of Q1 2026.
Harbour Investments left its Filana Therapeutics share count unchanged in Q1 2026.
Filana Therapeutics made up ﹤0.01% of Harbour Investments's portfolio in Q1 2026, its #4285 holding.
Harbour Investments first reported a position in Filana Therapeutics in Q1 2021 and has held it in 20 quarters since.
Harbour Investments's Filana Therapeutics position peaked at $91K in Q2 2021.
101 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2026.

Based on Harbour Investments's 13F filing for Q1 2026, filed 15 May 2026.